Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sinopharm Group Co. Ltd.

    OTC: SHTDY · Real-Time Price · USD
    11.83
    0.14 (1.20%)
    At close: Jun 27, 2025, 3:58 PM

    Sinopharm Statistics

    Share Statistics

    Sinopharm has 629.24M shares outstanding. The number of shares has increased by -0.33% in one year.

    Shares Outstanding

    n/a
    		 629.24M

    Shares Change (YoY)

    n/a
    		 -0.33%

    Shares Change (QoQ)

    n/a
    		 -0.4%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 1.34B

    Failed to Deliver (FTD) Shares

    n/a
    		 50

    FTD / Avg. Volume

    n/a
    		 0.35%

    Short Selling Information

    The latest short interest is 6.72K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.72K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 8.77 and the forward PE ratio is null. Sinopharm's PEG ratio is -0.4.

    PE Ratio

    n/a
    		 8.77

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.11

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0.78

    P/FCF Ratio

    n/a
    		 6.45

    PEG Ratio

    n/a
    		 -0.4
    Financial Ratio History

    Enterprise Valuation

    Sinopharm has an Enterprise Value (EV) of 331.16B.

    EV / Sales

    n/a
    		 0.57

    EV / EBITDA

    n/a
    		 15.43

    EV / EBIT

    n/a
    		 28.68

    EV / FCF

    n/a
    		 34.58

    Financial Position

    The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.97.

    Current Ratio

    n/a
    		 1.39

    Quick Ratio

    n/a
    		 1.14

    Debt / Equity

    n/a
    		 0.97

    Debt / EBITDA

    n/a
    		 3.56

    Debt / FCF

    n/a
    		 7.98

    Interest Coverage

    n/a
    		 5.92

    Financial Efficiency

    Return on Equity is 8.94% and Return on Invested Capital is 5.82%.

    Return on Equity

    n/a
    		 8.94%

    Return on Assets

    n/a
    		 1.79%

    Return on Invested Capital

    n/a
    		 5.82%

    Revenue Per Employee

    n/a
    		 $5,401,257.94

    Profits Per Employee

    n/a
    		 $65,143.95

    Employee Count

    n/a
    		 108,217

    Asset Turnover

    n/a
    		 1.49

    Inventory Turnover

    n/a
    		 8.66

    Taxes

    Income Tax

    n/a
    		 3.58B

    Effective Tax Rate

    n/a
    		 25.55%

    Stock Price Statistics

    The stock price has increased by -10.17% in the last 52 weeks. The beta is 0.59, so Sinopharm's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.59

    52-Week Price Change

    n/a
    		 -10.17%

    50-Day Moving Average

    n/a
    		 11.75

    200-Day Moving Average

    n/a
    		 12.49

    Relative Strength Index (RSI)

    n/a
    		 49.47

    Average Volume (20 Days)

    n/a
    		 14,266

    Income Statement

    In the last 12 months, Sinopharm had revenue of 584.51B and earned 7.05B in profits. Earnings per share was 11.3.

    Revenue

    n/a
    		 584.51B

    Gross Profit

    n/a
    		 44.26B

    Operating Income

    n/a
    		 16.19B

    Net Income

    n/a
    		 7.05B

    EBITDA

    n/a
    		 21.47B

    EBIT

    n/a
    		 16.73B

    Earnings Per Share (EPS)

    n/a
    		 11.3
    Full Income Statement

    Balance Sheet

    The company has 54.31B in cash and 76.39B in debt, giving a net cash position of -22.07B.

    Cash & Cash Equivalents

    n/a
    		 54.31B

    Total Debt

    n/a
    		 76.39B

    Net Cash

    n/a
    		 -22.07B

    Retained Earnings

    n/a
    		 53.74B

    Total Assets

    n/a
    		 392.83B

    Working Capital

    n/a
    		 97.07B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 11.55B and capital expenditures -1.97B, giving a free cash flow of 9.58B.

    Operating Cash Flow

    n/a
    		 11.55B

    Capital Expenditures

    n/a
    		 -1.97B

    Free Cash Flow

    n/a
    		 9.58B

    FCF Per Share

    n/a
    		 3.07
    Full Cash Flow Statement

    Margins

    Gross margin is 7.57%, with operating and profit margins of 2.77% and 1.21%.

    Gross Margin

    n/a
    		 7.57%

    Operating Margin

    n/a
    		 2.77%

    Pretax Margin

    n/a
    		 2.4%

    Profit Margin

    n/a
    		 1.21%

    EBITDA Margin

    n/a
    		 3.67%

    EBIT Margin

    n/a
    		 2.77%

    FCF Margin

    n/a
    		 1.64%

    Dividends & Yields

    SHTDY pays an annual dividend of $1.07, which amounts to a dividend yield of 4.05%.

    Dividend Per Share

    n/a
    		 $1.07

    Dividend Yield

    n/a
    		 4.05%

    Dividend Growth (YoY)

    n/a
    		 -21.58%

    Payout Ratio

    n/a
    		 68.3%

    Earnings Yield

    n/a
    		 11.4%

    FCF Yield

    n/a
    		 3.1%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SHTDY.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $56.5

    Lynch Upside

    n/a
    		 377.6%

    Graham Number

    n/a
    		 35.84

    Graham Upside

    n/a
    		 202.96%

    Scores

    Altman Z-Score

    n/a
    		 2.18

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist